SCHEMBL3517828

SCHEMBL3517828

CN(C)CCNS(=O)(=O)c1ccc(Nc2nccc(-c3ccc(NC(=O)Cc4cccs4)cc3)n2)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 8/20 0.72
POLB P06746 6/20 0.58
ESR2 Q92731 3/20 0.58
L3MBTL1 Q9Y468 3/20 0.58
CTDSP1 Q9GZU7 3/20 0.58
RECQL P46063 2/20 0.58
HSD17B10 Q99714 2/20 0.58
ESR1 P03372 2/20 0.58
DNMT1 P26358 1/20 0.58
ALDH1A1 P00352 3/20 0.57
MEN1 O00255 3/20 0.57
KMT2A Q03164 3/20 0.57
LMNA P02545 3/20 0.57
TDP1 Q9NUW8 1/20 0.57
CDK2 P24941 3/20 0.53
CDK1 P06493 1/20 0.52
CDK4 P11802 1/20 0.52
MAPT P10636 2/20 0.47
HPGD P15428 1/20 0.47
HTT P42858 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3516470 0.95 IKBKB (0.70) IKBKBPOLBESR2L3MBTL1CTDSP1
SCHEMBL3517708 0.91 IKBKB (0.78) IKBKBPOLBESR2L3MBTL1CTDSP1
SCHEMBL3519734 0.91 IKBKB (0.59) IKBKBPOLBESR2L3MBTL1CTDSP1
SCHEMBL3516801 0.89 IKBKB (0.74) IKBKBPOLBESR2L3MBTL1CTDSP1
SCHEMBL3518389 0.88 IKBKB (0.62) IKBKBPOLBESR2L3MBTL1CTDSP1
SCHEMBL3520829 0.87 IKBKB (0.65) IKBKBALDH1A1MEN1KMT2ALMNA
SCHEMBL3518983 0.87 IKBKB (0.61) IKBKBPOLBESR2L3MBTL1CTDSP1
SCHEMBL3520630 0.87 IKBKB (0.70) IKBKBMEN1KMT2ALMNACDK2
SCHEMBL3524640 0.86 IKBKB (0.73) IKBKBMEN1KMT2ACDK2CDK1
SCHEMBL3520303 0.84 IKBKB (1.00) IKBKBPOLBESR2L3MBTL1CTDSP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7799915-B2 Anilino-pyrimidine analogs WYETH LLC (US) 2010-09-21 US claimed
US-20060079543-A1 Anilino-pyrimidine analogs WYETH (US) 2006-04-13 US claimed
US-7799915-B2 Anilino-pyrimidine analogs WYETH LLC (US) 2010-09-21 US disclosed
US-20060079543-A1 Anilino-pyrimidine analogs WYETH (US) 2006-04-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060079543-A1 Anilino-pyrimidine analogs DPYD, TYMP, ADORA3 IKBKB 3246/4885POLB 203/4885ESR2 929/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.